GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

अन्य संस्करण दिखाएं (1)

ग्रंथसूची विवरण
मुख्य लेखकों:	Reinhardt, K, Kate, A, Bohmer, K, Vyas, P, Dirk, R
स्वरूप:	Conference item
प्रकाशित:	2010

समान संसाधन

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
द्वारा: Reinhardt, K, और अन्य
प्रकाशित: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
द्वारा: Alford, K, और अन्य
प्रकाशित: (2011)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
द्वारा: Maroz, A, और अन्य
प्रकाशित: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
द्वारा: Maroz, A, और अन्य
प्रकाशित: (2014)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
द्वारा: Garnett, C, और अन्य
प्रकाशित: (2019)

Myeloid pre-leukemia and leukemia of Down syndrome
द्वारा: Cruz Hernandez, D, और अन्य
प्रकाशित: (2020)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
द्वारा: Hasle, H, और अन्य
प्रकाशित: (2008)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
द्वारा: Hellebostad, M, और अन्य
प्रकाशित: (2005)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
द्वारा: Zhenzhen Yang, और अन्य
प्रकाशित: (2019-08-01)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
द्वारा: Cruz Hernandez, D, और अन्य
प्रकाशित: (2020)

Acute leukemias in children with Down syndrome.
द्वारा: Zwaan, C, और अन्य
प्रकाशित: (2010)

Acute leukemias in children with Down syndrome.
द्वारा: Zwaan, M, और अन्य
प्रकाशित: (2008)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
द्वारा: Norton, A, और अन्य
प्रकाशित: (2007)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
द्वारा: Labuhn, M, और अन्य
प्रकाशित: (2019)

Natural history of GATA-1 mutations in Down syndrome.
द्वारा: Ahmed, M, और अन्य
प्रकाशित: (2003)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
द्वारा: Brahim Arkoun, और अन्य
प्रकाशित: (2023-04-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
द्वारा: Tunstall-Pedoe, O, और अन्य
प्रकाशित: (2008)

Natural history of GATA1 mutations in Down syndrome.
द्वारा: Ahmed, M, और अन्य
प्रकाशित: (2004)

Down syndrome preleukemia and leukemia.
द्वारा: Maloney, K, और अन्य
प्रकाशित: (2014)

GATA2 DEFICIENCY SYNDROME: MDS / ACUTE MYELOID LEUKEMIA IN AN ADOLESCENT PATIENT
द्वारा: Sebnem Yilmaz, और अन्य
प्रकाशित: (2023-12-01)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
द्वारा: Heald, B, और अन्य
प्रकाशित: (2007)

A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
द्वारा: Ana C Xavier, और अन्य
प्रकाशित: (2011-01-01)

DNMT3A mutations are rare in childhood acute myeloid leukemia
द्वारा: Felicitas Thol, और अन्य
प्रकाशित: (2011-08-01)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
द्वारा: Halsey, C, और अन्य
प्रकाशित: (2006)

Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of <i>GATA1</i> and <i>STAG2</i> Mutations in Induced Pluripotent Stem Cells with Trisomy 21
द्वारा: Sonali P. Barwe, और अन्य
प्रकाशित: (2022-02-01)

GATA1 mutational analysis in chronic myeloid leukaemia.
द्वारा: Halsey, C, और अन्य
प्रकाशित: (2007)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
द्वारा: Roberts, I, और अन्य
प्रकाशित: (2013)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
द्वारा: Marius Flasinski, और अन्य
प्रकाशित: (2018-07-01)

Molecular insights into Down syndrome-associated leukemia.
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2007)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
द्वारा: Li Yang, और अन्य
प्रकाशित: (2017-01-01)

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia
द्वारा: Jasmijn D.E. de Rooij, और अन्य
प्रकाशित: (2015-05-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
द्वारा: Maximiliano Cloobs Venezia, और अन्य
प्रकाशित: (2022-11-01)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
द्वारा: Li Yang, और अन्य
प्रकाशित: (2017-01-01)

GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells
द्वारा: Koichi R. Katsumura, और अन्य
प्रकाशित: (2016-08-01)

Myelodysplastic syndrome due to somatic GATA1 mutation.
द्वारा: Freson, K, और अन्य
प्रकाशित: (2004)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation
द्वारा: Yoko Nishinaka-Arai, और अन्य
प्रकाशित: (2020-04-01)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
द्वारा: Chompoonut Limratchapong, और अन्य
प्रकाशित: (2023-03-01)

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
द्वारा: Marlise R. Luskin, और अन्य
प्रकाशित: (2015-10-01)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
द्वारा: Bernhard Moser, और अन्य
प्रकाशित: (2021-08-01)